PAK1-dependent MAPK pathway activation is required for colorectal cancer cell proliferation
Authors:
- 18 January 2012
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 33 (4) , 985-994
Abstract
P21-activated protein kinase1 (PAK1), a main downstream effector of small Rho GTPases, Rac1, and Cdc42, plays an important role in the regulation of cell morphogenesis, motility, mitosis, and angiogenesis. Despite its importance, the molecular mechanisms of PAK1 that contributed to colorectal carcinogenesis remain unclear. Our immunohistochemistry showed that PAK1 expression was increased with colorectal cancer (CRC) progression through the adenoma to carcinoma sequence. Furthermore, our results suggested a relationship between PAK1 nuclear localization and the Dukes staging. In the present study, we showed that PAK1 knockdown decreased proliferation and delayed the G1/S cell-cycle transition, and increased apoptosis in vivo and in vitro. In addition, PAK1 knock-down downregulated c-Jun amino terminal kinases (JNK) activity and the levels of cyclinD1, CDK4/6. Inhibition of the JNK activity by chemical inhibitor (SP600125) significantly reduced the effects of PAK1 on CRC proliferation via accumulation of phosphatase and tensin homolog deleted on chromosome 10 (PTEN). In conclusion, our results demonstrate that knockdown of PAK1 could enhance the chemosensitivity of CRCs to 5-fluorouracil through G1 arrest. The mechanism by which PAK1 induced cancer growth might involve activation of JNK as well as downregulation of PTEN. Targeting PAK1 may represent a novel treatment strategy for developing novel chemotherapeutic agents.Keywords
This publication has 41 references indexed in Scilit:
- Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated Kinase-1BMC Immunology, 2009
- P21‐activated kinase 5 is overexpressed during colorectal cancer progression and regulates colorectal carcinoma cell adhesion and migrationInternational Journal of Cancer, 2009
- Pak protein kinases and their role in cancerCancer and Metastasis Reviews, 2009
- Phosphorylated Pak1 Level in the Cytoplasm Correlates with Shorter Survival Time in Patients with GlioblastomaClinical Cancer Research, 2007
- The GIT-Associated Kinase PAK Targets to the Centrosome and Regulates Aurora-AMolecular Cell, 2005
- Inhibition of c-Jun-N-terminal-Kinase Sensitizes Tumor Cells to CD95-Induced Apoptosis and Induces G2/M Cell Cycle ArrestCancer Research, 2005
- C–Jun–N–Terminal Kinase Drives Cyclin D1 Expression and Proliferation During Liver RegenerationHepatology, 2003
- Caspase activation and disruption of mitochondrial membrane potential during UV radiation-induced apoptosis of human keratinocytes requires activation of protein kinase CCell Death & Differentiation, 2002
- AP-1 in cell proliferation and survivalOncogene, 2001
- c-Jun N-terminal Kinase Is Essential for Growth of Human T98G Glioblastoma CellsJournal of Biological Chemistry, 2000